Available evidence suggests that the incidence of leukemia and lymphoma tends to be
higher in highly developed regions of the world and among Whites in the United States …

Hodgkin lymphoma is a rare B-cell malignant neoplasm affecting approximately 9000 new
patients annually. This disease represents approximately 11% of all lymphomas seen in the …

Background The contribution of hereditary factors to the causation of sporadic cancer is
unclear. Studies of twins make it possible to estimate the overall contribution of inherited …

Abstract Disease Overview Hodgkin lymphoma (HL) is an uncommon B‐cell lymphoid
malignancy affecting 8500 new patients annually and representing approximately 10.2% of …

Our understanding of familial predisposition to lymphoma (collectively defined as non-
Hodgkin lymphoma [NHL], Hodgkin lymphoma [HL], and chronic lymphocytic leukemia …

Identical infant twins with concordant leukemia were first described in 1882, and since that
time many such pairs of infants and older children have been described. It has long been …

Hodgkin lymphoma (HL) is a B cell lymphoma characterized by few malignant cells and
numerous immune effector cells in the tumour microenvironment. The incidence of HL is …

Epstein–Barr virus (EBV), a ubiquitous B-lymphotrophic herpesvirus, has been found in the
tumor cells of a heterogeneous group of malignancies (Burkitt's lymphoma, lymphomas …

Hodgkin lymphoma (HL) is a rare malignancy accounting for roughly 15% of all lymphomas
and mostly affecting young patients. A second peak is seen in patients above 60 years of …

The TEL (ETV6)− AML1 (CBFA2) gene fusion is the most common reciprocal chromosomal
rearrangement in childhood cancer occurring in≈ 25% of the most predominant subtype of …